The World Health Organization (WHO) has recently sounded a global warning over the rapidly growing burden of cancer, projecting that the number of new cases could rise to nearly 35 million annually by 2050 unless countries take urgent and coordinated action to strengthen prevention, early detection and equitable access to treatment. The warning comes in the WHO Global Status Report on Cancer 2026, prepared jointly with the International Agency for Research on Cancer (IARC), which presents a comprehensive assessment of the world’s progress in tackling one of the leading causes of death.
The report estimates that approximately 20.6 million people are diagnosed with cancer every year, while nearly 10 million lose their lives to the disease. This translates into more than 26,000 deaths every day, making cancer the second leading cause of mortality worldwide after cardiovascular diseases. Although remarkable advances have been made in scientific research, early diagnosis and treatment, the report concludes that these benefits continue to be distributed unevenly, leaving millions without access to essential services.
According to WHO, the projected increase in cancer cases is being driven by a combination of population growth, ageing, urbanisation and the increasing prevalence of preventable risk factors such as tobacco use, obesity, unhealthy diets, physical inactivity, alcohol consumption and environmental pollution. Unless these underlying causes are addressed through sustained public health measures, the burden of cancer is expected to grow substantially over the coming decades.
A central concern highlighted in the report is the widening gap between countries with strong health systems and those with limited healthcare infrastructure. Survival rates for several common cancers vary dramatically depending on where a patient lives. Breast cancer illustrates this disparity clearly. While women diagnosed in high-income countries have significantly higher survival rates because of widespread screening programmes, timely diagnosis and access to advanced treatment, women in low-income countries continue to face much poorer outcomes due to delayed detection, shortages of specialised care and limited treatment facilities.
The report also notes that comprehensive cancer care remains beyond the reach of millions. Less than one-third of countries currently include cancer services within their universal health coverage packages, leaving many patients to bear enormous out-of-pocket expenses. Access to essential cancer medicines remains particularly inadequate in low- and lower-middle-income countries, where the availability of priority medicines is far below that seen in wealthier nations. The shortage of diagnostic equipment, radiotherapy facilities, oncology specialists and pathology services further compounds the challenge.
Beyond its medical consequences, cancer continues to impose a profound social and economic burden on families and communities. WHO’s first global survey involving people affected by cancer reveals that the disease often results in severe financial hardship, psychological distress and long-term disruption to family life. Nearly half of those surveyed reported experiencing financial difficulties arising from treatment costs, loss of income and related expenses. Mental health concerns, including anxiety and depression, were reported by more than half of respondents, while caregivers described considerable physical, emotional and social strain as they struggled to balance caregiving responsibilities with employment and household obligations.
The report makes it clear that cancer is no longer solely a health issue but also a major development challenge affecting economic productivity, household stability and social well-being. Families frequently face catastrophic health expenditures, and many patients discontinue or delay treatment because they cannot afford prolonged medical care.
Regional variations in the global cancer burden remain striking. Asia accounts for more than half of all cancer cases and deaths worldwide, largely because it is home to the largest share of the global population. Europe, despite representing only a small proportion of the world’s population, carries a disproportionately high share of both cancer cases and deaths. In contrast, many countries across Africa and parts of Asia continue to record comparatively lower incidence rates but much higher mortality because cancers are often detected at advanced stages and treatment facilities remain inadequate or inaccessible.
Among individual cancers, lung cancer continues to be the leading cause of cancer-related deaths worldwide. It remains one of the most commonly diagnosed cancers among men, alongside prostate and colorectal cancers. Among women, breast cancer continues to account for the largest share of cases, followed by lung and colorectal cancers. These patterns underline the continuing need for effective screening programmes, improved awareness and strengthened preventive measures.
The report estimates that nearly four out of every ten cancer cases worldwide are linked to preventable risk factors. Tobacco remains the single largest avoidable cause, while alcohol consumption, obesity, unhealthy diets and lack of physical activity continue to contribute significantly to the growing disease burden. Infections such as human papillomavirus (HPV), hepatitis B and C viruses and Helicobacter pylori also account for a substantial proportion of cancers, particularly in low- and middle-income countries. WHO stresses that expanding vaccination programmes, promoting healthier lifestyles and reducing exposure to environmental risks could prevent millions of future cancer cases.
Despite the grim projections, the report also documents encouraging progress in several areas. Global tobacco use has declined significantly since 2010, contributing to reductions in lung cancer incidence in countries that have implemented comprehensive tobacco-control policies. Expanded vaccination against HPV and hepatitis B has begun to reduce infection-related cancers, while improvements in water, sanitation and infection control have further strengthened prevention efforts.
Political commitment towards cancer control has also improved over the past decade. More than four-fifths of countries now have national cancer control plans, compared with only half in 2010. Screening programmes for breast and cervical cancer have expanded considerably in many high-income countries, allowing cancers to be detected at earlier and more treatable stages. Scientific innovation has accelerated as well, with a steady increase in cancer-related clinical trials leading to the development of more effective diagnostic tools, targeted therapies and personalised treatment approaches.
Nevertheless, WHO cautions that scientific progress alone will not reduce the global cancer burden unless these advances become accessible to all populations. Many low-income countries continue to lack even the most basic cancer services, creating profound inequalities in survival and quality of life. The organisation argues that future investments must focus not only on developing new technologies but also on ensuring that existing lifesaving interventions reach those who need them most.
The report advocates a fundamental shift towards a people-centred approach to cancer control. Such an approach places individuals and families at the heart of health systems by integrating prevention, early diagnosis, treatment, rehabilitation, palliative care and psychosocial support within universal health coverage. It also recognises that effective cancer care extends beyond hospitals and requires social protection measures that reduce the financial burden on patients while ensuring dignity throughout the course of illness.
WHO has called upon governments, international organisations, academic institutions, civil society and the private sector to work together in strengthening health systems and addressing persistent inequalities. Greater investment in healthcare personnel, cancer registries, laboratory services, screening programmes and affordable medicines is considered essential if countries are to cope with the anticipated increase in cases over the coming decades.
organisation believes that the projected rise in cancer cases is neither inevitable nor irreversible. Evidence from countries that have implemented comprehensive prevention policies demonstrates that substantial reductions in cancer incidence and mortality are achievable through sustained public health interventions. Expanding vaccination coverage, reducing tobacco and alcohol use, promoting healthier lifestyles, improving environmental conditions and ensuring timely access to quality healthcare remain among the most effective strategies for reducing the future burden of the disease.
As cancer continues to affect millions of individuals and families across every region of the world, the report serves as a reminder that the decisions governments make today will determine health outcomes for future generations. Closing the gap between scientific advances and equitable access to care, strengthening prevention efforts and placing people at the centre of health systems will be crucial in changing the trajectory of one of the world’s most pressing public health challenges.
The author is a senior analyst and environmentalist. Feedback can be sent to [email protected]. Twitter/X: @haniefmha
